NewslettersCell Therapy NewsHematopoiesis NewsHuman Immunology NewsPoseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic MalignanciesBy Danielle Corrigan - August 3, 20220232Poseida Therapeutics, Inc. announced it has entered into a broad strategic collaboration and license agreement with Roche, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies.[Poseida Therapeutics, Inc.]Press Release